Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry (STRATEGY-IT)
A Prospective Evaluation of a Standardized Strategy for the Use of Bioresorbable Vascular Scaffold in ST-segment Elevation Myocardial Infarction: the BVS STEMI STRATEGY-IT Registry
Sponsor: Azienda Ospedaliera Bolognini di Seriate Bergamo
A PHASE4 clinical study on ST-elevation Myocardial Infarction (STEMI), this trial is ongoing. The trial is conducted by Azienda Ospedaliera Bolognini di Seriate Bergamo and has accumulated 6 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Mar 2022 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Active Not Recruiting PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliera Bolognini di Seriate Bergamo
For direct contact, visit the study record on ClinicalTrials.gov .